Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 195,500 shares at $0.20 ($40K) on 2020-11-10, disclosed to the SEC on 2020-11-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.21 | 60,000 | $13K | 31.3% |
| 2 | $0.20 | 6,500 | $1K | 3.2% |
| 3 | $0.20 | 8,000 | $2K | 4.0% |
| 4 | $0.20 | 10,000 | $2K | 5.0% |
| 5 | $0.20 | 22,000 | $4K | 10.9% |
| 6 | $0.21 | 10,000 |
| $2K |
| 5.2% |
| 7 | $0.22 | 37,500 | $8K | 20.5% |
| 8 | $0.19 | 25,500 | $5K | 12.0% |
| 9 | $0.20 | 6,000 | $1K | 3.0% |
| 10 | $0.20 | 10,000 | $2K | 5.0% |
| Total | $0.21 avg | 195,500 | $40K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |
| LXRP | BUY | 2016-08-25 | $3K | — | Filing → |